Journal of the Chinese Medical Association

Papers
(The H4-Index of Journal of the Chinese Medical Association is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
Clinical manifestation and disease progression in COVID-19 infection125
ChatGPT and other artificial intelligence applications speed up scientific writing102
ChatGPT failed Taiwan’s Family Medicine Board Exam51
Performance of ChatGPT on the Pharmacist Licensing Examination in Taiwan44
Classification and citation analysis of the 100 top-cited articles on adult spinal deformity since 2011: A bibliometric analysis36
Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver27
Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma26
The impact of COVID-19 in pregnancy: Part II. Vaccination to pregnant women24
The role of micronutrient and immunomodulation effect in the vaccine era of COVID-1924
The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-1921
Increased antibiotic exposure in early life is associated with adverse outcomes in very low birth weight infants19
Accurate diagnosis of endoscopic mucosal healing in ulcerative colitis using deep learning and machine learning18
Combined effects of hypertension, hyperlipidemia, and diabetes mellitus on the presence and severity of carotid atherosclerosis in community-dwelling elders: A community-based study18
Animal models of dry eye: Their strengths and limitations for studying human dry eye disease18
Organ- or function-preservation surgery is recommended, but who is a candidate?17
MiR-194-5p serves as a potential biomarker and regulates the proliferation and apoptosis of hippocampus neuron in children with temporal lobe epilepsy17
Combination of pembrolizumab and lenvatinib is a potential treatment option for heavily pretreated recurrent and metastatic head and neck cancer17
To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases17
To do one and to get more: Part I. Diabetes and bone17
0.051542997360229